Table 1.
Results of visual analog scale questionnaire during the follow-up visits.
| Pressure |
Nose blockage |
Headache |
Nasal pain |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | C | p | N | C | p | N | C | p | N | C | p | |
| Day 2 n = 50 |
3.03 (±3.01) | 3.26 (±2.93) | 0.15 | 4.26 (±2.98) | 4.73 (±2.79) | 0.04 | 3.41 (±3.1) | 3.48 (±2.91) | 0.79 | 3.32 (±3.29) | 3.14 (±2.99) | 0.37 |
| Day 10 n = 49 |
1.9 (±1.93) | 2.16 (±1.99) | 0.04 | 1.81 (±1.79) | 2.59 (±1.85) | 0.02 | 1.78 (±1.88) | 2.06 (±2.01) | 0.14 | 1.8 (±1.86) | 2.08 (±2.14) | 0.10 |
| Day 30 n = 49 |
0.23 (±0.58) | 0.45 (±1.22) | 0.06 | 0.45 (±0.96) | 0.68 (±1.68) | 0.62 | 0.28 (±0.55) | 0.4 (±0.78) | 0.11 | 0.38 (±0.93) | 0.4 (±0.78) | 0.49 |
N, Nasopore; C, control; n, number of patients.